MoneyWorks4Me

Bharat Parenterals - Quaterly Results

03 Feb 2025 Evaluate
A fair growth of 14.52% in the revenue at Rs. 673.40 millions was reported in the December 2024 quarter as compared to Rs. 588.00 millions during year-ago period.Good  Net Profit growth of 28.21% reported above the corresponding previous quarter figure of Rs. 50.70 millions to Rs. 65.00 millioins.Operating profit for the quarter ended December 2024 rose to 121.40 millions as compared to 91.80 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 673.40 588.00 14.52 2238.50 1885.20 18.74 2541.60 2179.80 16.60
Other Income 37.90 24.00 57.92 122.90 87.10 41.10 119.50 188.40 -36.57
PBIDT 121.40 91.80 32.24 412.80 334.10 23.56 403.90 402.10 0.45
Interest 14.10 6.10 131.15 33.10 21.00 57.62 31.90 21.90 45.66
PBDT 107.30 85.70 25.20 379.70 313.10 21.27 372.00 380.20 -2.16
Depreciation 18.60 16.70 11.38 52.20 47.90 8.98 64.00 58.50 9.40
PBT 88.70 69.00 28.55 327.50 265.20 23.49 308.00 321.70 -4.26
TAX 23.70 18.30 29.51 85.80 70.10 22.40 82.10 78.30 4.85
Deferred Tax -1.50 -3.90 -61.54 -6.65 -0.60 1008.33 -4.50 -5.70 -21.05
PAT 65.00 50.70 28.21 241.70 195.10 23.89 225.90 243.40 -7.19
Equity 68.92 57.75 19.34 68.92 58.20 18.42 58.20 57.70 0.87
PBIDTM(%) 18.03 15.61 15.47 18.44 17.72 4.05 15.89 18.45 -13.85
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..